ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has voluntarily announced that the company has noticed unusual share price movements but assures that there are no undisclosed material facts or inside information affecting the market. They confirm that business operations and financial position remain stable, with no material adverse changes, and remind shareholders and potential investors to trade with caution.
For further insights into HK:1541 stock, check out TipRanks’ Stock Analysis page.
